Patient Safety

Adverse Event Reporting

Your safety is our priority. Report any adverse events related to Mefloquine tablets.

What is an Adverse Event?

An adverse event is any undesirable medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment.

At Taj Pharma, we are committed to monitoring the safety of our Mefloquine Hydrochloride Tablets USP 250mg and encourage healthcare professionals and patients to report any suspected adverse events.

How to Report Adverse Events

You can report adverse events to any of the following authorities:

Taj Pharma Pharmacovigilance

Primary Contact for Taj Pharma Products

Email: pv@tajpharma.com

Phone: +91 22-6973 8917

24/7 Helpline: +91 84484 44095

WhatsApp: +91 74 0000 9975

National Regulatory Authority

CDSCO - Central Drugs Standard Control Organization

Website: www.cdsco.gov.in

PVPI: Pharmacovigilance Programme of India

Email: pvpi@cdsco.gov.in

Toll-Free: 1800-180-3024

WHO Pharmacovigilance Programme

World Health Organization Global Safety Monitoring

Website: www.who.int/pharmacovigilance

Uppsala Monitoring Centre: WHO Collaborating Centre

Email: viglywho@who.int

Global Database: VigiBase

Taj Pharma Adverse Event Reporting Form

Use this form to report adverse events directly to Taj Pharma's pharmacovigilance department.

Important Information

📞 24/7 Reporting

Adverse events can be reported 24/7 through our helpline numbers.

🔒 Confidential

All reports are treated with strict confidentiality and processed according to regulatory requirements.

⚡ Urgent Reporting

For serious or unexpected adverse events, please report immediately.

🌍 Global Reporting

Reports are shared with global pharmacovigilance databases for worldwide safety monitoring.